Key facts
- Alora (Aquaculture)’s last known valuation is $3.1M (Oct 2019).
- It has raised $1.6M; the latest was Later Stage VC in Mar 2026.
- Notable investors include SOSV, IndieBio, Toyota Ventures, Neglected Climate Opportunities, Mistletoe — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Alora (Aquaculture)
- ·The full record, as it builds
Funding rounds
No funding rounds for Alora (Aquaculture) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alora (Aquaculture)
Developer of gene-edited crop traits designed to improve yield and resilience under heat and salinity stress. The company uses system-level gene editing to optimize plant energy utilization, enabling crops to maintain performance in climate-challenged and high-salinity environments while reducing reliance on freshwater and arable land.
- Sector
- Healthcare
- HQ
- Norwich, United Kingdom
- Founded
- 2019
- Employees
- 8
- Website
- alora.world/
- Ownership
- Privately Held (backing)
Alora (Aquaculture) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alora (Aquaculture) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alora (Aquaculture) in its N-PORT filings yet. We sweep new filings monthly.